NFE2L2 and Alzheimer disease: According to a study carried out by Murphy et al., the intranasal administration of mini-GAGR in the 3xTg-AD mouse models is able to increase the activity of antioxidant enzymes that are Nrf2-dependent, decreasing the levels of ROS [11].